Key facts
- It has raised $69.3M; the latest was Later Stage VC in Nov 2025.
- Notable investors include BDC Capital, Garage Capital, MaRS Investment Accelerator Fund, Government of Canada, Business Development Bank of Canada — 27 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Nicoya (Devices and Supplies)
- ·The full record, as it builds
Funding rounds
No funding rounds for Nicoya (Devices and Supplies) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nicoya (Devices and Supplies)
Operator of a biotechnology company intended to specialize in biosensor technology for the academic and biopharmaceutical sectors. The company develops an integrated surface plasmon resonance system that is capable of accelerating drug discovery using a fraction of the sample volume traditionally required for biomolecular interaction analyses, enabling scientists to accelerate label-free biomolecular analysis and their research with quality data.
- Sector
- Healthcare
- HQ
- Kitchener, Canada
- Founded
- 2012
- Employees
- 124
- Website
- nicoyalife.com/
- Ownership
- Privately Held (backing)
Nicoya (Devices and Supplies) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nicoya (Devices and Supplies) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nicoya (Devices and Supplies) in its N-PORT filings yet. We sweep new filings monthly.